Hogan Lovells advises VAPIANO SE on capital increase

Led by Frankfurt partner Michael Schlitt international law firm Hogan Lovells advised VAPIANO SE on a capital increase against cash contributions through the partial use of its authorised capital, under the exclusion of shareholders' pre-emptive subscription rights.

As part of the transaction, the company issued 2,033,418 new bearer shares with dividend entitlements for the fiscal year 2018. The commitment of the company's main shareholders, Mayfair Beteiligungsfond II GmbH & Co. KG, VAP Leipzig GmbH & Co. KG und Exchange Bio GmbH, was utilized in full. The placement price was set at EUR 10.00, bringing the gross issuance proceeds from the capital increase to EUR 20,334,180.00.

Hogan Lovells Team for VAPIANO SE

Prof. Dr. Michael Schlitt (Partner), Guido Brockhausen (Counsel), Dr. Susanne Lenz (Counsel), Dušan Stojković (Senior Associate), Carlos Landschein, Andreas Mildner, Maurice Heine (Capital Markets and Corporate Law, Frankfurt and Düsseldorf); 

Jonathan Baird (Partner, US Law, London); 

Dr. Katlen Blöcker (Partner), Dr. Maximilian Zembala (Senior Associate), Maria Eugenia Fojo (Foreign Associate) (Banking and Finance Law, Frankfurt).

Back To Listing